JY
NDRA icon

Jeff Yass’s ENDRA Life Sciences NDRA Stock Holding History

Jeff Yass’s Portfolio NDRA Stock Details NDRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-22
Closed -$3.67K – 12664
2024
Q2 		$3.67K Buy
+22
New +$9.47K ﹤0.01% 11831
2023
Q2 		– Sell
-7
Closed -$28.7K – 12768
2023
Q1 		$28.7K Buy
+7
New +$47.5K ﹤0.01% 11929
2020
Q2 		– Sell
-2
Closed -$38K – 10641
2020
Q1 		$38K Buy
+2
New +$92.7K ﹤0.01% 9768
2019
Q4 		– Hold
0
– – – 9484
2019
Q3 		– Hold
0
– – – 9992
2018
Q2 		– Hold
0
– -$40K – 10118
2018
Q1 		– Hold
0
– – – 9017

Other funds holding NDRA

VF
Virtu Financial New York $3.18B AUM 65.92% 1-Year Est. Return
TSS
Two Sigma Securities New York $1.16B AUM 36.23% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
JF
Jump Financial Chicago, Illinois $12.4B AUM 62.79% 1-Year Est. Return
HF
HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
NA
NewEdge Advisors New Orleans, Louisiana $33.6B AUM 31.03% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Jeff Yass's NDRA Position: Q3 2024 in Review

Jeff Yass sold out of ENDRA Life Sciences (NDRA) in Q3 2024, closing a stake of 22 shares — an estimated $3.67K sold.

Jeff Yass first reported a position in NDRA in Q1 2020 and held it in 3 quarters. The position peaked at $38K in Q1 2020. 9 funds tracked by Wall St. Rank hold NDRA as of Q3 2024.

  • Jeff Yass reported no remaining ENDRA Life Sciences position as of Q3 2024 after selling out during the quarter.
  • Jeff Yass sold 22 ENDRA Life Sciences shares in Q3 2024, an estimated $3.67K.
  • Jeff Yass first reported a position in ENDRA Life Sciences in Q1 2020 and held it in 3 quarters.
  • Jeff Yass's ENDRA Life Sciences position peaked at $38K in Q1 2020.
  • 9 funds tracked by Wall St. Rank held ENDRA Life Sciences as of Q3 2024.

Based on Susquehanna International Group's 13F filing for Q3 2024, filed 14 Nov 2024.